Synthetic bio-industry has entered a period of rapid development, attracting giants to beach layout

"In the next 10 to 20 years, the economic value of $4 trillion will be dominated by synthetic organisms.
" is McKinsey's recognition of the future value of the synthetic biology industry in its june report, "The Biological Revolution: Innovation Will Change the Economy, Society, and Our Lives."
Synthesis biotechnology is a revolutionary new technology, which is to use biomass as raw material or biological methods for large-scale material processing and transformation, to produce the industrial commodities necessary for social development, and the production process is green, mild conditions, high economy, can effectively solve environmental pollution, safety risks and other problems.
biotechnology is also thought to be the next biotechnology revolution, an important part of the fourth industrial revolution.
In November 2019, China's Ministry of Science and Technology issued a letter on supporting the construction of the National Synthetic Biotechnology Innovation Center, which mentions that the layout and construction of the National Synthetic Biotechnology Innovation Center is of strategic and practical significance for breaking through the technical bottlenecks in China's pharmaceutical, food, petrochemical and other fields, grabbing the commanding heights of global biotechnology and industrial development, and promoting green and sustainable economic and social development.
the letter, the innovation center should take key technology research and development as its core mission to provide the source technology supply for the development of synthetic bio-related industries.
we should accelerate the transfer and transformation of scientific and technological achievements, build a carrier of innovative entrepreneurship incubation services, support researchers to carry out innovation and entrepreneurship with the transformation of scientific and technological achievements as the core, and foster the incubation of a number of small and medium-sized enterprises with core competitiveness.
by the market, policies and a series of positive factors, the current synthetic biological industry is developing at a high speed, and aimed at the field of synthetic biology, many giants are making efforts.
October 11, Kaiser Bio issued an out-of-country investment announcement, the company will join hands with Shanxi Province to invest in the creation of "Shanxi synthetic bio-industry ecological park", and plans to invest in the industrial park and the company's existing main business-related industrialization projects, including biological long-chain binary acid, bio-based diamine, bio-based polyamide and so on.
company's capital contribution amounted to 4.01 billion yuan.
public information shows that Kaiser Bio is a high-tech enterprise based on synthetic biology and other disciplines, using bioman manufacturing technology, engaged in the research and development, production and sale of new bio-based materials.
For this investment, the company said that is the embodiment of its industrial chain layout strategy, through participation in the construction of circular economic integration industrial park project investment, in the moderate expansion of biological long-chain binary acid, bio-based diamine and bio-based polyamide and other core product production capacity at the same time, is conducive to close cooperation with the downstream industrial chain, and constantly optimize the product structure and industrial chain layout, so that the company in the industrial chain occupies a more favorable competitive position.
, the capital market is also optimistic about the development of biosynthetic industry space, and constantly increase the size of the field.
, for example, announced in September that it had completed a $15 million round A financing.
this round of financing by latitude and longitude China led investment, Sherba Investment, BV Baidu venture capital and other institutions to follow the investment.
previously, Enerdy had also received seed wheel investments from Nest Life Capital.
it is understood that the current round of funds will be used to accelerate the construction of technology platforms and the development of existing product pipelines.
public information shows that En and Bio, a biotech company based on the concept of synthetic biology, has developed a computational-based enzyme engineering, strain engineering and fermentation process engineering platform, covering the entire process from product development to large-scale industrialization.
through the three major technological pathways of bio-catalysis, bio-transformation and biosynthesis, En and Bio-hope to meet the diverse market needs of the bio-manufacturing sector.